drugset / Trial / NCT00003396
Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Phase 2
Completed
42 enrolled
University of Maryland, Baltimore
University of Maryland Greenebaum Cancer Center · collab
Treatment
Summary
RATIONALE: Peripheral stem cell transplantation may be able to replace immune cells that were destroyed by chemotherapy or radiation therapy used to kill tumor cells. PURPOSE: Phase II trial to study the effectiveness of peripheral stem cell transplantation from related donors to prevent graft-versus-host disease in treating patients with hematologic cancer.
Timeline
- Start
- 1998-09
- Primary completion
- 2002-12
- Completion
- 2002-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | ANTILYMPHOCYTE IMMUNOGLOBULIN (HORSE) | Protein / enzyme biologic | — | Intravenous |
| Background | Cyclophosphamide | Other / unclassified | — | Intravenous |
| Background | Melphalan | Small molecule | — | Intravenous |